These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29281685)

  • 1. Nanoparticle size and production efficiency are affected by the presence of fatty acids during albumin nanoparticle fabrication.
    Luebbert CC; Clarke TM; Pointet R; Frahm GE; Tam S; Lorbetskie B; Sauvé S; Johnston MJW
    PLoS One; 2017; 12(12):e0189814. PubMed ID: 29281685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of supplier-to-supplier and lot-to-lot variability in glycation of recombinant human serum albumin expressed in Oryza sativa.
    Frahm GE; Smith DG; Kane A; Lorbetskie B; Cyr TD; Girard M; Johnston MJ
    PLoS One; 2014; 9(10):e109893. PubMed ID: 25299339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the differences in thermal stability of two recombinant human serum albumins with 1,2-dipalmitoyl-sn-glycero-3-phosphocholine liposomes by UV circular dichroism spectropolarimetry.
    Frahm GE; Cyr TD; Smith DG; Walrond LD; Johnston MJ
    J Phys Chem B; 2012 Apr; 116(15):4661-70. PubMed ID: 22423959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human serum albumin (HSA) nanoparticles: reproducibility of preparation process and kinetics of enzymatic degradation.
    Langer K; Anhorn MG; Steinhauser I; Dreis S; Celebi D; Schrickel N; Faust S; Vogel V
    Int J Pharm; 2008 Jan; 347(1-2):109-17. PubMed ID: 17681686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Investigation of the Subtle Structural Discrepancies between Oryza Sativa Recombinant and Plasma-Derived Human Serum Albumins to Design a Novel Nanoparticle as a Taxane Delivery System.
    Fang R; He L; Wang Y; Wang L; Qian H; Yang S
    Protein J; 2024 Jun; 43(3):544-558. PubMed ID: 38581543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large-scale production of functional human serum albumin from transgenic rice seeds.
    He Y; Ning T; Xie T; Qiu Q; Zhang L; Sun Y; Jiang D; Fu K; Yin F; Zhang W; Shen L; Wang H; Li J; Lin Q; Sun Y; Li H; Zhu Y; Yang D
    Proc Natl Acad Sci U S A; 2011 Nov; 108(47):19078-83. PubMed ID: 22042856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unfolding properties of recombinant human serum albumin products are due to bioprocessing steps.
    Lang BE; Cole KD
    Biotechnol Prog; 2015; 31(1):62-9. PubMed ID: 25270911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robust size control of bovine serum albumin (BSA) nanoparticles by intermittent addition of a desolvating agent and the particle formation mechanism.
    Paik SY; Nguyen HH; Ryu J; Che JH; Kang TS; Lee JK; Song CW; Ko S
    Food Chem; 2013 Nov; 141(2):695-701. PubMed ID: 23790836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cells.
    Ulbrich K; Michaelis M; Rothweiler F; Knobloch T; Sithisarn P; Cinatl J; Kreuter J
    Int J Pharm; 2011 Mar; 406(1-2):128-34. PubMed ID: 21185364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxorubicin-loaded glycyrrhetinic acid modified recombinant human serum albumin nanoparticles for targeting liver tumor chemotherapy.
    Qi WW; Yu HY; Guo H; Lou J; Wang ZM; Liu P; Sapin-Minet A; Maincent P; Hong XC; Hu XM; Xiao YL
    Mol Pharm; 2015 Mar; 12(3):675-83. PubMed ID: 25584860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human serum albumin from recombinant DNA technology: challenges and strategies.
    Chen Z; He Y; Shi B; Yang D
    Biochim Biophys Acta; 2013 Dec; 1830(12):5515-25. PubMed ID: 23644036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human serum albumin binding to silica nanoparticles--effect of protein fatty acid ligand.
    Ang JC; Henderson MJ; Campbell RA; Lin JM; Yaron PN; Nelson A; Faunce T; White JW
    Phys Chem Chem Phys; 2014 Jun; 16(21):10157-68. PubMed ID: 24595605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical and immunochemical properties of recombinant human serum albumin from Pichia pastoris.
    Ohtani W; Nawa Y; Takeshima K; Kamuro H; Kobayashi K; Ohmura T
    Anal Biochem; 1998 Feb; 256(1):56-62. PubMed ID: 9466797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of Bovine Serum Albumin (BSA) nanoparticles by desolvation using a membrane contactor: a new tool for large scale production.
    Yedomon B; Fessi H; Charcosset C
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):398-405. PubMed ID: 23811438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of fatty acids from 1,2-dipalmitoyl-sn-glycero-3-phosphocholine/cardiolipin liposomes that stabilize recombinant human serum albumin.
    Frahm GE; Cameron BE; Smith JC; Johnston MJ
    J Liposome Res; 2013 Jun; 23(2):101-9. PubMed ID: 23294393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotoxicity assessment of rice-derived recombinant human serum albumin using human peripheral blood mononuclear cells.
    Fu K; Cheng Q; Liu Z; Chen Z; Wang Y; Ruan H; Zhou L; Xiong J; Xiao R; Liu S; Zhang Q; Yang D
    PLoS One; 2014; 9(8):e104426. PubMed ID: 25099245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desolvation process and surface characteristics of HSA-nanoparticles.
    Weber C; Kreuter J; Langer K
    Int J Pharm; 2000 Mar; 196(2):197-200. PubMed ID: 10699717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of bound dodecanoic acid on the reconstitution of albumin nanoparticles from a lyophilized state.
    Luebbert CCE; Mansa R; Rahman R; Jakubek ZJ; Frahm GE; Zou S; Johnston MJW
    Sci Rep; 2021 Feb; 11(1):4768. PubMed ID: 33637809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desolvation process and surface characterisation of protein nanoparticles.
    Weber C; Coester C; Kreuter J; Langer K
    Int J Pharm; 2000 Jan; 194(1):91-102. PubMed ID: 10601688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin and paclitaxel co-bound lactosylated albumin nanoparticles having targetability to hepatocellular carcinoma.
    Thao LQ; Lee C; Kim B; Lee S; Kim TH; Kim JO; Lee ES; Oh KT; Choi HG; Yoo SD; Youn YS
    Colloids Surf B Biointerfaces; 2017 Apr; 152():183-191. PubMed ID: 28110040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.